Review




Structured Review

Pasteur Institute normal human foreskin fibroblast cell line c163
MTT assay results on <t>melanoma</t> <t>(DFW)</t> and fibroblast <t>(HFF)</t> cell lines at 24 hours. A. The survival rate of DFW and HFF cells incubated with different concentrations of GNP@ICG in 24 hours. The concentration of 10 μM which caused 10% cell death was selected for following treatments. B. The survival percentage of cells treated with radiotherapy. C. The survival percentage of cells treated with CAP. D. The viability of the cells treated to 2 Gy RT following NPs and CAP (30 and 60 seconds) immediately and 24 hours later. Data are shown as the mean ± SD (n=3). A comparison of the difference between each group and the control group was presented as *; P<0.05, **; P<0.01, and ***; P<0.001. CAP; Cold atmospheric plasma, NPs; GNP@ICG, RT; Radiotherapy, 30s+2Gy/0h; Combined therapy 30-seconds CAP and 2 Gy radiation immediately, 30s+2Gy/24h; Ccombined therapy 30-seconds CAP and 2 Gy radiation with 24 hours interval, 60 s+2Gy/0h; Combined therapy 60-seconds CAP and 2 Gy radiation immediately, and 60s+2Gy/24h; Combined therapy 60-seconds CAP and 2 Gy radiation with 24 hours interval.
Normal Human Foreskin Fibroblast Cell Line C163, supplied by Pasteur Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/normal human foreskin fibroblast cell line c163/product/Pasteur Institute
Average 90 stars, based on 1 article reviews
normal human foreskin fibroblast cell line c163 - by Bioz Stars, 2026-03
90/100 stars

Images

1) Product Images from "The Synergistic Effect of Cold Atmospheric Plasma Mediated Gold Nanoparticles Conjugated with Indocyanine Green as An Innovative Approach to Cooperation with Radiotherapy"

Article Title: The Synergistic Effect of Cold Atmospheric Plasma Mediated Gold Nanoparticles Conjugated with Indocyanine Green as An Innovative Approach to Cooperation with Radiotherapy

Journal: Cell Journal (Yakhteh)

doi: 10.22074/CELLJ.2022.559078.1097

MTT assay results on melanoma (DFW) and fibroblast (HFF) cell lines at 24 hours. A. The survival rate of DFW and HFF cells incubated with different concentrations of GNP@ICG in 24 hours. The concentration of 10 μM which caused 10% cell death was selected for following treatments. B. The survival percentage of cells treated with radiotherapy. C. The survival percentage of cells treated with CAP. D. The viability of the cells treated to 2 Gy RT following NPs and CAP (30 and 60 seconds) immediately and 24 hours later. Data are shown as the mean ± SD (n=3). A comparison of the difference between each group and the control group was presented as *; P<0.05, **; P<0.01, and ***; P<0.001. CAP; Cold atmospheric plasma, NPs; GNP@ICG, RT; Radiotherapy, 30s+2Gy/0h; Combined therapy 30-seconds CAP and 2 Gy radiation immediately, 30s+2Gy/24h; Ccombined therapy 30-seconds CAP and 2 Gy radiation with 24 hours interval, 60 s+2Gy/0h; Combined therapy 60-seconds CAP and 2 Gy radiation immediately, and 60s+2Gy/24h; Combined therapy 60-seconds CAP and 2 Gy radiation with 24 hours interval.
Figure Legend Snippet: MTT assay results on melanoma (DFW) and fibroblast (HFF) cell lines at 24 hours. A. The survival rate of DFW and HFF cells incubated with different concentrations of GNP@ICG in 24 hours. The concentration of 10 μM which caused 10% cell death was selected for following treatments. B. The survival percentage of cells treated with radiotherapy. C. The survival percentage of cells treated with CAP. D. The viability of the cells treated to 2 Gy RT following NPs and CAP (30 and 60 seconds) immediately and 24 hours later. Data are shown as the mean ± SD (n=3). A comparison of the difference between each group and the control group was presented as *; P<0.05, **; P<0.01, and ***; P<0.001. CAP; Cold atmospheric plasma, NPs; GNP@ICG, RT; Radiotherapy, 30s+2Gy/0h; Combined therapy 30-seconds CAP and 2 Gy radiation immediately, 30s+2Gy/24h; Ccombined therapy 30-seconds CAP and 2 Gy radiation with 24 hours interval, 60 s+2Gy/0h; Combined therapy 60-seconds CAP and 2 Gy radiation immediately, and 60s+2Gy/24h; Combined therapy 60-seconds CAP and 2 Gy radiation with 24 hours interval.

Techniques Used: MTT Assay, Incubation, Concentration Assay

Flow cytometry results of DFW and HFF cell lines. A. The Annexin-V-FITC assay for detecting the apoptosis and necrosis of DFW cells, B. The diagram of the percentage of apoptotic and necrotic of DFW cells after treatment with different groups, C. The Annexin-V-FITC assay for detecting the apoptosis and necrosis of HFF cells, and D. The diagram of percentage of apoptotic and necrotic of HFF cells in different groups. DFW; Melanoma cell line, HFF; Health foreskin fibroblast, CAP; Cold atmospheric plasma, NPs; GNP@ICG, RT; Radiotherapy, 30s+2Gy/0h; Combined therapy 30-seconds CAP and 2 Gy radiation immediately, 30s+2Gy/24h; Ccombined therapy 30-seconds CAP and 2 Gy radiation with 24 hours interval, 60 s+2Gy/0h; Combined therapy 60-seconds CAP and 2 Gy radiation immediately, and 60s+2Gy/24h; Combined therapy 60-seconds CAP and 2 Gy radiation with 24 hours interval.
Figure Legend Snippet: Flow cytometry results of DFW and HFF cell lines. A. The Annexin-V-FITC assay for detecting the apoptosis and necrosis of DFW cells, B. The diagram of the percentage of apoptotic and necrotic of DFW cells after treatment with different groups, C. The Annexin-V-FITC assay for detecting the apoptosis and necrosis of HFF cells, and D. The diagram of percentage of apoptotic and necrotic of HFF cells in different groups. DFW; Melanoma cell line, HFF; Health foreskin fibroblast, CAP; Cold atmospheric plasma, NPs; GNP@ICG, RT; Radiotherapy, 30s+2Gy/0h; Combined therapy 30-seconds CAP and 2 Gy radiation immediately, 30s+2Gy/24h; Ccombined therapy 30-seconds CAP and 2 Gy radiation with 24 hours interval, 60 s+2Gy/0h; Combined therapy 60-seconds CAP and 2 Gy radiation immediately, and 60s+2Gy/24h; Combined therapy 60-seconds CAP and 2 Gy radiation with 24 hours interval.

Techniques Used: Flow Cytometry



Similar Products

90
Pasteur Institute normal human foreskin fibroblast cell line c163
MTT assay results on <t>melanoma</t> <t>(DFW)</t> and fibroblast <t>(HFF)</t> cell lines at 24 hours. A. The survival rate of DFW and HFF cells incubated with different concentrations of GNP@ICG in 24 hours. The concentration of 10 μM which caused 10% cell death was selected for following treatments. B. The survival percentage of cells treated with radiotherapy. C. The survival percentage of cells treated with CAP. D. The viability of the cells treated to 2 Gy RT following NPs and CAP (30 and 60 seconds) immediately and 24 hours later. Data are shown as the mean ± SD (n=3). A comparison of the difference between each group and the control group was presented as *; P<0.05, **; P<0.01, and ***; P<0.001. CAP; Cold atmospheric plasma, NPs; GNP@ICG, RT; Radiotherapy, 30s+2Gy/0h; Combined therapy 30-seconds CAP and 2 Gy radiation immediately, 30s+2Gy/24h; Ccombined therapy 30-seconds CAP and 2 Gy radiation with 24 hours interval, 60 s+2Gy/0h; Combined therapy 60-seconds CAP and 2 Gy radiation immediately, and 60s+2Gy/24h; Combined therapy 60-seconds CAP and 2 Gy radiation with 24 hours interval.
Normal Human Foreskin Fibroblast Cell Line C163, supplied by Pasteur Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/normal human foreskin fibroblast cell line c163/product/Pasteur Institute
Average 90 stars, based on 1 article reviews
normal human foreskin fibroblast cell line c163 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


MTT assay results on melanoma (DFW) and fibroblast (HFF) cell lines at 24 hours. A. The survival rate of DFW and HFF cells incubated with different concentrations of GNP@ICG in 24 hours. The concentration of 10 μM which caused 10% cell death was selected for following treatments. B. The survival percentage of cells treated with radiotherapy. C. The survival percentage of cells treated with CAP. D. The viability of the cells treated to 2 Gy RT following NPs and CAP (30 and 60 seconds) immediately and 24 hours later. Data are shown as the mean ± SD (n=3). A comparison of the difference between each group and the control group was presented as *; P<0.05, **; P<0.01, and ***; P<0.001. CAP; Cold atmospheric plasma, NPs; GNP@ICG, RT; Radiotherapy, 30s+2Gy/0h; Combined therapy 30-seconds CAP and 2 Gy radiation immediately, 30s+2Gy/24h; Ccombined therapy 30-seconds CAP and 2 Gy radiation with 24 hours interval, 60 s+2Gy/0h; Combined therapy 60-seconds CAP and 2 Gy radiation immediately, and 60s+2Gy/24h; Combined therapy 60-seconds CAP and 2 Gy radiation with 24 hours interval.

Journal: Cell Journal (Yakhteh)

Article Title: The Synergistic Effect of Cold Atmospheric Plasma Mediated Gold Nanoparticles Conjugated with Indocyanine Green as An Innovative Approach to Cooperation with Radiotherapy

doi: 10.22074/CELLJ.2022.559078.1097

Figure Lengend Snippet: MTT assay results on melanoma (DFW) and fibroblast (HFF) cell lines at 24 hours. A. The survival rate of DFW and HFF cells incubated with different concentrations of GNP@ICG in 24 hours. The concentration of 10 μM which caused 10% cell death was selected for following treatments. B. The survival percentage of cells treated with radiotherapy. C. The survival percentage of cells treated with CAP. D. The viability of the cells treated to 2 Gy RT following NPs and CAP (30 and 60 seconds) immediately and 24 hours later. Data are shown as the mean ± SD (n=3). A comparison of the difference between each group and the control group was presented as *; P<0.05, **; P<0.01, and ***; P<0.001. CAP; Cold atmospheric plasma, NPs; GNP@ICG, RT; Radiotherapy, 30s+2Gy/0h; Combined therapy 30-seconds CAP and 2 Gy radiation immediately, 30s+2Gy/24h; Ccombined therapy 30-seconds CAP and 2 Gy radiation with 24 hours interval, 60 s+2Gy/0h; Combined therapy 60-seconds CAP and 2 Gy radiation immediately, and 60s+2Gy/24h; Combined therapy 60-seconds CAP and 2 Gy radiation with 24 hours interval.

Article Snippet: DFW (human melanoma cell line, C496) and HFF (normal human foreskin fibroblast cell line, C163) were purchased from Pasteur Institute in Iran.

Techniques: MTT Assay, Incubation, Concentration Assay

Flow cytometry results of DFW and HFF cell lines. A. The Annexin-V-FITC assay for detecting the apoptosis and necrosis of DFW cells, B. The diagram of the percentage of apoptotic and necrotic of DFW cells after treatment with different groups, C. The Annexin-V-FITC assay for detecting the apoptosis and necrosis of HFF cells, and D. The diagram of percentage of apoptotic and necrotic of HFF cells in different groups. DFW; Melanoma cell line, HFF; Health foreskin fibroblast, CAP; Cold atmospheric plasma, NPs; GNP@ICG, RT; Radiotherapy, 30s+2Gy/0h; Combined therapy 30-seconds CAP and 2 Gy radiation immediately, 30s+2Gy/24h; Ccombined therapy 30-seconds CAP and 2 Gy radiation with 24 hours interval, 60 s+2Gy/0h; Combined therapy 60-seconds CAP and 2 Gy radiation immediately, and 60s+2Gy/24h; Combined therapy 60-seconds CAP and 2 Gy radiation with 24 hours interval.

Journal: Cell Journal (Yakhteh)

Article Title: The Synergistic Effect of Cold Atmospheric Plasma Mediated Gold Nanoparticles Conjugated with Indocyanine Green as An Innovative Approach to Cooperation with Radiotherapy

doi: 10.22074/CELLJ.2022.559078.1097

Figure Lengend Snippet: Flow cytometry results of DFW and HFF cell lines. A. The Annexin-V-FITC assay for detecting the apoptosis and necrosis of DFW cells, B. The diagram of the percentage of apoptotic and necrotic of DFW cells after treatment with different groups, C. The Annexin-V-FITC assay for detecting the apoptosis and necrosis of HFF cells, and D. The diagram of percentage of apoptotic and necrotic of HFF cells in different groups. DFW; Melanoma cell line, HFF; Health foreskin fibroblast, CAP; Cold atmospheric plasma, NPs; GNP@ICG, RT; Radiotherapy, 30s+2Gy/0h; Combined therapy 30-seconds CAP and 2 Gy radiation immediately, 30s+2Gy/24h; Ccombined therapy 30-seconds CAP and 2 Gy radiation with 24 hours interval, 60 s+2Gy/0h; Combined therapy 60-seconds CAP and 2 Gy radiation immediately, and 60s+2Gy/24h; Combined therapy 60-seconds CAP and 2 Gy radiation with 24 hours interval.

Article Snippet: DFW (human melanoma cell line, C496) and HFF (normal human foreskin fibroblast cell line, C163) were purchased from Pasteur Institute in Iran.

Techniques: Flow Cytometry